Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neurol

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    April 2022
  1. DURAN-PENA A, Ducray F, Ramirez C, Bauchet L, et al
    Adult brainstem glioma differential diagnoses: an MRI-based approach in a series of 68 patients.
    J Neurol. 2022 Apr 20. pii: 10.1007/s00415-022-11070.
    PubMed     Abstract available


    October 2021
  2. MAZZUCCHI E, Vollono C, Pauletto G, Lettieri C, et al
    The persistence of seizures after tumor resection negatively affects survival in low-grade glioma patients: a clinical retrospective study.
    J Neurol. 2021 Oct 25. pii: 10.1007/s00415-021-10845.
    PubMed     Abstract available


  3. KUHN S, Sonksen SE, Jakobs F, Zschommler Y, et al
    Do arachnoid cysts grow? A retrospective volumetric study.
    J Neurol. 2021;268:3777-3780.
    PubMed     Abstract available


    September 2021
  4. CORDANI R, Veneruso M, Napoli F, Milanaccio C, et al
    Correction to: Sleep disturbances in craniopharyngioma: a challenging diagnosis.
    J Neurol. 2021 Sep 24. pii: 10.1007/s00415-021-10814.
    PubMed    


  5. CORDANI R, Veneruso M, Napoli F, Milanaccio C, et al
    Sleep disturbances in craniopharyngioma: a challenging diagnosis.
    J Neurol. 2021 Sep 14. pii: 10.1007/s00415-021-10794.
    PubMed     Abstract available


    August 2021
  6. LEIBETSEDER A, Leitner J, Mair MJ, Meckel S, et al
    Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature.
    J Neurol. 2021 Aug 3. pii: 10.1007/s00415-021-10725.
    PubMed     Abstract available


  7. UNGUREANU A, Le Garff-Tavernier M, Costopoulos M, Parratte T, et al
    CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
    J Neurol. 2021;268:2890-2894.
    PubMed     Abstract available


    July 2021
  8. O SULLIVAN C, Zach F, Moser T, Pilz G, et al
    Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events.
    J Neurol. 2021 Jul 24. pii: 10.1007/s00415-021-10707.
    PubMed    


  9. LIN X, Lu T, Deng H, Liu C, et al
    Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.
    J Neurol. 2021 Jul 20. pii: 10.1007/s00415-021-10660.
    PubMed     Abstract available


  10. SWAN D, Seiffge DJ, Thachil J
    A review of anticoagulation in patients with central nervous system malignancy: between a rock and a hard place.
    J Neurol. 2021;268:2390-2401.
    PubMed     Abstract available


    June 2021
  11. MARKU M, Rasmussen BK, Belmonte F, Hansen S, et al
    Prediagnosis epilepsy and survival in patients with glioma: a nationwide population-based cohort study from 2009 to 2018.
    J Neurol. 2021 Jun 24. pii: 10.1007/s00415-021-10668.
    PubMed     Abstract available


    April 2021
  12. RENARD D, Collombier L, Laurent-Chabalier S, Mura T, et al
    (18)F-FDOPA-PET in pseudotumoral brain lesions.
    J Neurol. 2021;268:1266-1275.
    PubMed     Abstract available


    February 2021
  13. VILLANI V, Anghileri E, Prosperini L, Lombardi G, et al
    Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology).
    J Neurol. 2021 Feb 20. pii: 10.1007/s00415-021-10438.
    PubMed     Abstract available


    November 2020
  14. VAN KESSEL E, Huenges Wajer IMC, Ruis C, Seute T, et al
    Cognitive impairments are independently associated with shorter survival in diffuse glioma patients.
    J Neurol. 2020 Nov 19. pii: 10.1007/s00415-020-10303.
    PubMed     Abstract available


    October 2020
  15. MORASSI M, Bigni B, Cobelli M, Giudice L, et al
    Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence?
    J Neurol. 2020;267:2812-2814.
    PubMed    


    August 2020
  16. DECAVELE M, Gatulle N, Weiss N, Rivals I, et al
    One-year survival of patients with high-grade glioma discharged alive from the intensive care unit.
    J Neurol. 2020 Aug 29. pii: 10.1007/s00415-020-10191.
    PubMed     Abstract available


    June 2020
  17. KIRBY AJ, Finnerty GT
    New strategies for managing adult gliomas.
    J Neurol. 2020 Jun 15. pii: 10.1007/s00415-020-09884.
    PubMed     Abstract available


    January 2020
  18. PETRELLI F, De Stefani A, Ghidini A, Bruschieri L, et al
    Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis.
    J Neurol. 2020 Jan 30. pii: 10.1007/s00415-020-09731.
    PubMed     Abstract available


    December 2019
  19. WANG FX, Chen K, Huang FQ, Alolga RN, et al
    Cerebrospinal fluid-based metabolomics to characterize different types of brain tumors.
    J Neurol. 2019 Dec 10. pii: 10.1007/s00415-019-09665.
    PubMed     Abstract available


    November 2019
  20. PINA Y, Fusco MJ, Macaulay RJ, Walko CM, et al
    Using personalized medicine in gliomas: a genomic approach to diagnosis and overcoming treatment resistance in a case with pleomorphic xanthoastrocytoma.
    J Neurol. 2019 Nov 21. pii: 10.1007/s00415-019-09575.
    PubMed     Abstract available


    September 2019
  21. ROMOLI M, Mandarano M, Romozzi M, Eusebi P, et al
    Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events.
    J Neurol. 2019;266:2273-2276.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: